According to Future Market Insights (FMI), the U.K. Biopsy Device Market is poised to expand at a CAGR of 3.9% during the assessment period, reaching a valuation of US$ 159 Million by 2033. Germany’s biopsy device market is likely to accelerate at a CAGR of 4.1% during the anticipated timeframe with overall sales anticipated to …
Category Archives: Healthcare Trends
Europe Balloon Catheter Market to Witness Billion $ Opportunity Amid Rising Prevalence of Peripheral Artery Disease | United Kingdom to Hold Lion’s Share, Exceeding US$ 273.4 Million by 2033
The United Kingdom Balloon Catheter Market is expected to reach a total of US$ 273.4 million by 2033, and likely to expand at a steady CAGR of 4.8% from 2023 to 2033. Germany balloon catheter market is also set to expand at a steady 4.7% CAGR, and the sales of balloon catheter is anticipated to …
Hematopoietic Stem Cell Transplantation to Hog Limelight in Europe from 2023 to 2033 | FMI Foresees a Healthy 7.6% CAGR
As per the report published by Future Market Insights (FMI), the Hematopoietic Stem Cell Transplantation (HSCT) market in Europe is projected to accelerate at a CAGR of 7.6% from 2023 to 2033. Leukemia and lymphoproliferative disorders are among the most common types of medical conditions in Europe and reported cases have been steadily rising in …
Korea’s Development of Petconomy is Changing the Way Companion Animal Specialty Drug Manufacturers Operate
South Koreans are expected to spend US$ 3 billion on their pets in 2020 and more than US$ 3.5 billion in 2021, resulting in an increase in pet-related businesses in Korea. According to the Korea Rural Economic Institute, this figure is expected to reach US$ 5 billion by 2027, creating opportunities for Korea’s companion animal specialty …
Treatment-Resistant Depression Treatment Market is expected to reach US$ 4 Billion by 2033
In 2023, the global Treatment-Resistant Depression Treatment Market is anticipated to be worth US$ 1.69 billion. Because of the rising frequency of depression and anxiety disorders in adults, as well as the ageing population, the global demand for treatment-resistant depression treatment is expected to expand at a CAGR of 9.0% between 2023 and 2033, totaling …
Hematology Diagnostics Market is expected to surpass US$ 2.0 billion by 2033
The Hematology Diagnostics Market is expected to be worth $780.0 million in 2023 and $2.0 billion by 2033. During the forecast period, the market for hematology diagnostics is expected to grow at a CAGR of 9.9%. The increasing chronic diseases such as cancer, blood clots, blood-related disorders, and infections are driving market opportunities. Moreover, growing …
Continue reading “Hematology Diagnostics Market is expected to surpass US$ 2.0 billion by 2033”
Hand Eczema Treatment Market is expected to grow with a 8% CAGR through 2033
The global Hand Eczema (HE) Treatment Market is predicted to generate a market value of US$ 53 Million in 2023 and a market value of US$ 114.42 Million by 2033, with a CAGR of 8% from 2023 to 2033. In the historical period 2018 to 2022, the market for Hand Eczema (HE) Treatment grew at …
Continue reading “Hand Eczema Treatment Market is expected to grow with a 8% CAGR through 2033”
Bispecific Antibody Market is expected to reach US$ 1 billion by 2033, at a CAGR 7.2%
The global bispecific antibody market is expected to reach $500 million by the end of 2023, and $1 billion by 2033, representing a 7.2% CAGR. The bispecific antibody business has benefited greatly from antibody engineering. Much progress has been achieved in generating innovative antibody formats and engineering procedures that allow the creation of bispecific antibodies …
Gastrointestinal Stromal Tumor Therapeutics Market to Register 6% CAGR in 2023 to 2033
During the forecast period 2023 to 2033, the Gastrointestinal Stromal Tumor (GIST) Therapeutics Market is expected to grow at a value of 6% CAGR, according to Future Market Insights. By the year 2033, the global market for Gastrointestinal stromal tumor (GIST) therapeutics is expected to rise up to a market valuation of US$ 1593 Million. …
Monoclonal Gammopathy of Undetermined Significance Management Market to surpass US$ 53.11 million by 2033
The global monoclonal gammopathy of undetermined significance (MGUS) management market is estimated to generate a market value of US$ 27 million in 2023 and a market value of US$ 53.11 million by 2033, growing at a CAGR of 7% from 2023 to 2033. The market for Monoclonal Gammopathy of Undetermined Significance (MGUS) Management grew at …